167 related articles for article (PubMed ID: 30103307)
1. Savitzky-Golay filter based contrast-enhanced ultrasound quantification in hepatic tumors: Methodology and its correlation with tumor angiogenesis.
Peng S; Ding H; Fu T; Wang B; Wang W; Zhou J
Clin Hemorheol Microcirc; 2019; 73(2):271-282. PubMed ID: 30103307
[TBL] [Abstract][Full Text] [Related]
2. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
[TBL] [Abstract][Full Text] [Related]
3. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.
Tian H; Wang Q
Eur J Cancer; 2016 Nov; 68():82-89. PubMed ID: 27728840
[TBL] [Abstract][Full Text] [Related]
5. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
Schaible J; Stroszczynski C; Beyer LP; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
Huang Z; Wu X; Li S; Li K
Ultrasound Med Biol; 2020 Jun; 46(6):1403-1411. PubMed ID: 32165015
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma.
Wang Z; Tang J; An L; Wang W; Luo Y; Li J; Xu J
J Ultrasound Med; 2007 Jun; 26(6):757-62. PubMed ID: 17526607
[TBL] [Abstract][Full Text] [Related]
8. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology.
Xiao JD; Zhu WH; Shen SR
Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):605-10. PubMed ID: 21134829
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization.
Pei XQ; Liu LZ; Zheng W; Cai MY; Han F; He JH; Li AH; Chen MS
Eur J Radiol; 2012 Mar; 81(3):e182-8. PubMed ID: 21349669
[TBL] [Abstract][Full Text] [Related]
11. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.
Kuorda H; Abe T; Fujiwara Y; Okamoto T; Yonezawa M; Sato H; Endo K; Oikawa T; Sawara K; Takikawa Y
World J Gastroenterol; 2019 May; 25(19):2365-2372. PubMed ID: 31148907
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS).
Wildner D; Schellhaas B; Strack D; Goertz RS; Pfeifer L; Fiessler C; Neurath MF; Strobel D
Clin Hemorheol Microcirc; 2019; 71(1):39-51. PubMed ID: 29865043
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis.
Xia Y; Jiang YX; Dai Q; Xiao Y; Lv K; Wang L
Clin Hemorheol Microcirc; 2011; 48(4):265-73. PubMed ID: 22012832
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.
Ryu H; Kim JH; Lee S; Han JK
PLoS One; 2020; 15(12):e0244304. PubMed ID: 33362203
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors.
Ainora ME; Cerrito L; Liguori A; Mignini I; De Luca A; Galasso L; Garcovich M; Riccardi L; Ponziani F; Santopaolo F; Pompili M; Gasbarrini A; Zocco MA
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239893
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of dynamic three-dimensional contrast-enhanced ultrasound in focal liver lesions: Image quality evaluation and correlation of quantification with two-dimensional contrast-enhanced ultrasound.
Cao J; Dong Y; Fan P; Mao F; Wang W
Clin Hemorheol Microcirc; 2019; 72(3):305-316. PubMed ID: 30856104
[TBL] [Abstract][Full Text] [Related]
18. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
